Virtu Financial LLC Myriad Genetics Inc Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$13.91 - $21.32 $311,111 - $476,843	22,366 New	22,366 $428,000
Q2 2020 Aug 07, 2020	SELL	$10.69 - $16.49 $87,401 - $134,822	-8,176 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$20.93 - $35.1 $171,123 - $286,977	8,176 New	8,176 $223,000
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $160,072 - $247,135	-7,061 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$26.93 - $34.7 $190,152 - $245,016	7,061 New	7,061 $234,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.